Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

Front Pharmacol. 2020 Oct 7:11:598261. doi: 10.3389/fphar.2020.598261. eCollection 2020.

Authors

Gloria Ravegnini¹, Marzia Del Re², Ambra A Grolla³, Ron H N van Schaik⁴, Sabrina Angelini¹

Affiliations

¹ Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
² Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
³ Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy.
⁴ Department of Clinical Chemistry, Erasmus MC, Rotterdam, Netherlands.

No abstract available

Keywords: Circulating molecular marker; ctDNA (circulating tumor DNA); liquid biopsy; personalized medicine; precision oncology.

Publication types

Editorial